PBMWW
Psyence Biomedical Ltd. WarrantKey Statistics
About Psyence Biomedical Ltd. Warrant
Psyence Biomedical Ltd. is a pioneering entity in the psychedelic industry, focused on the research, development, and commercialization of psilocybin-based therapies aimed at addressing pressing mental health challenges, including anxiety and depression. With a commitment to rigorous scientific research and compliance with regulatory standards, the company is strategically positioned to leverage its substantial intellectual property portfolio as societal attitudes toward psychedelics evolve. By providing innovative therapeutic solutions, Psyence aims to become a key player in the expanding field of mental health treatment, tapping into a significant market opportunity driven by increasing recognition of the potential benefits of psychedelics in clinical applications.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-4.15M |
| Operating Margin | 0.00% |
| Return on Equity | -74.30% |
| Return on Assets | -34.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $39.62 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 292,590 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |